ArticleVeterinary research communications2026
Etiological and immunological aspects of equine hoof canker.
Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Chronic equine proliferative pododermatitis (canker) is a hypertrophic hoof disease characterized by excessive proliferation of horn-producing tissues resulting from dyskeratosis of keratinocytes. Since its etiology remains unknown, this study investigated potential etiological agents and evaluated biochemical and immunological profiles. Ten horses with hoof canker and ten healthy controls of the Norik of Muran breed were included. Dermatophytes and bovine papillomavirus 1 and 2 (BPV 1/2) were not detected. Candida glabrata was the most frequently identified species in both affected and healthy groups. In horses with canker, Aspergillus fumigatus, Mucor spp., and Trichosporon spp. were also detected. Biochemical analysis showed significantly higher creatine kinase myoglobin binding activity in affected horses compared to controls (12.58 ± 5.86 vs. 4.11 ± 1.57; p < 0.01), with a slight increase in aspartate aminotransferase activity. Principal component analysis revealed substantial overlap between healthy and affected groups. Immunologically, monocyte phagocytic activity was significantly reduced in affected horses (83.78% ± 3.40 vs. 90.26% ± 2.88; p < 0.001). Affected horses had increased CD4
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.